Why the Microbiome Matters in the ICU
The potentially transformative role of the microbiome in managing infectious and inflammatory diseases in critically ill patients and leading to more personalised innovative microbiome-targeted therapeutics is explored in an article in press in the Journal of Critical Care. “The evolving field of microbiome research is likely to transform the current culture-based paradigm of clinical practice in the ICU”, write Georgios Kitsios, MD, University of Pittsburgh School of Medicine, and colleagues, adding: “the microbiome is the current big revolution in the post-genomics era.”
In their article Kitsios and colleagues define the microbiome concepts and terminology and provide a systematic review of the evidence on the critical illness microbiome in relation to acute respiratory failure and ARDS, and sepsis, including 51 animal and human studies.
See Also: Study: Microbiome Disruption May Have Key Role in ARDS, Sepsis
“If we think of the microbiome as an internalised organ with physiologically important functions, then it becomes evident that microbiome disruptions can be harmful, similar to other “organ failures” in the ICU with damage both by the “organ” function being lost and also the aberrant physiology replacing that function,” they write.
Kitsios and colleagues also include a roadmap for future studies in the field that covers conceptual design, experimental design and conduct, analytics and information synthesis, validation and dissemination.
They conclude: “We can envision a time in the not-too distant future when the microbiome will be viewed as yet another organ system of the critically-ill patient, requiring special attention and plan of care during our daily ICU
Image credit, with permission: This originally appeared in the Hartford Courant.
«« 7 Variables Predict ICU Readmission: New Tool
NIV After Cardiothoracic Surgery Reviewed »»
Published on : Wed, 19 Oct 2016
StatStrip® and StatStrip Xpress®2 Glucose Meters
The only glucose meters cleared by US FDA and Health Canada for use with all patients, including critically ill Because of the unacceptably high rate of adverse patient events, including deaths, linked to the point-of-care (POC) use of glucose...
Transport of ECLS patients
The Xenios MultiSupport GROUND (MSG) is a system consisting of different components, designed to enable inner- and inter-hospital transport of severely ill patients undergoing life-saving extracorporeal heart and lung support. As a whole, the Xenios...
Stat Profile Prime® ES Plus Analyzer
Not available in all markets Exceptional Simplicity in a New Generation Electrolyte Analyzer Introducing a new generation electrolyte analyzer that combines the revolutionary microelectronics of the consumer world with new microsensor...
IVD CAPSULE PSP
For Early Sepsis Detection
IVD CAPSULE PSP The IVD CAPSULE PSP is a rapid, single-use in vitro diagnostic test for the quantitative measurement of pancreatic stone protein (PSP) in blood. The test is intended to be used in conjunction with other clinical assessments and laboratory...
StatStrip® and StatStrip Xpress®2 Glucose/Ketone Meters
Not yet available in the U.S. The most extensively studied and proven glucose measurement technology In addition to studies submitted to the FDA, 168 other independent studies over the last eight years—including 53 critical care studies—have...